Microbot Medical MBOT Stock Issuance Proceeds
Stock Issuance Proceeds at other companies
Other financials
Where this comes from
Reported directly by Microbot Medical in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOrSaleOfEquity.
The official record: Microbot Medical’s 10-K, filed March 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Microbot Medical's stock issuance proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Microbot Medical's stock issuance proceeds?
- Microbot Medical (MBOT) reported stock issuance proceeds of $86.24M in Q4 2025.
- How has Microbot Medical's stock issuance proceeds changed year-over-year?
- Microbot Medical's stock issuance proceeds increased by 2945.1% year-over-year, from $2.83M to $86.24M.
- What is the long-term trend for Microbot Medical's stock issuance proceeds?
- Over 2 years (2022 to 2024), Microbot Medical's stock issuance proceeds has grown at a 35.5% compound annual growth rate (CAGR), from $4.32M to $7.94M.
- What does stock issuance proceeds mean?
- Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.